CtrlK
Syndax Pharmaceuticals
SNDX51
$13.30arrow_drop_up2.34%$0.30
NASDAQ - As of Apr 30, 5:48 AM EDT Market Closed
SNDX51
$13.30
arrow_drop_up2.34%Performance History
There's no data available for performance history chart
| Key Stats | |
|---|---|
| Open | $13.05 |
| Prev. Close | $13.00 |
| EPS | -3.64 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $992.94M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 12.51 | 14.07 |
| 52 Week Range | 9.73 | 25.34 |
| Ratios | |
|---|---|
| P/B Ratio | 3.64 |
| Revenue | - |
| Operating M. % | -716.62% |
| Earnings | $0.00 |
| Earnings Growth % | -40.19% |
| EBITDA Margin % | - |
| ROE % | -81.88% |
| EPS | -3.64 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
There's no data available for Analyst Forecast
Period: -
• Predicted: -Analyst Ratings
There's no data available for Analyst Ratings
Last updated: -
• Total: -Correlated Companies
About Syndax Pharmaceuticals (SNDX)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Michael A. Metzger M.B.A.
- Headquarters
- Waltham
- Employees
- 107
- Exchange
- NASDAQ
Keep an eye on Syndax Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Syndax Pharmaceuticals 's (SNDX) price per share?
The current price per share for Syndax Pharmaceuticals (SNDX) is $13.3. The stock has seen a price change of $0.3 recently, indicating a 2.35% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Syndax Pharmaceuticals (SNDX)?
For Syndax Pharmaceuticals (SNDX), the 52-week high is $25.34, which is 90.53% from the current price. The 52-week low is $9.73, the current price is 36.69% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Syndax Pharmaceuticals (SNDX) a growth stock?
Syndax Pharmaceuticals (SNDX) has shown an average price growth of -1.65% over the past three years. It has received a score of 61 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Syndax Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Syndax Pharmaceuticals (SNDX) stock price performance year to date (YTD)?
As of the latest data, Syndax Pharmaceuticals (SNDX) has a year-to-date price change of 0.61%. Over the past month, the stock has experienced a price change of -3.13%. Over the last three months, the change has been -7.7%. Over the past six months, the figure is -28.26%. Looking at a longer horizon, the five-year price change stands at 10.74%.
help
Is Syndax Pharmaceuticals (SNDX) a profitable company?
Syndax Pharmaceuticals (SNDX) has a net income of -$209.36M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -716.62% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$229.95M. Furthermore, the EBITDA is -$321.2M.
help
What is the market capitalization of Syndax Pharmaceuticals (SNDX)?
Syndax Pharmaceuticals (SNDX) has a market capitalization of $992.95M. The average daily trading volume is 13.19, indicating the stock's liquidity and investor engagement.